ABOUT PHARMA EXCIPIENTS

“The existing situation has exposed some structural weaknesses during the EU’s medicines source chain as well as a superior dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides claimed. She recommended that provide chain problems be addressed within an EU pharmaceutical method expected to be launched by the end of y